Investors of Indian pharmaceutical companies are worried about the prospect of further escalation amid U.S. trade tensions.

U.S. customs officials said on Thursday they were investigating whether Indian solar company Waaree Energies sidestepped U.S.

US tariffs on patented drugs won’t hit Indian pharma immediately, says Bhaskar Chakravorti, but future risk to generics ...

From the start of October, imported branded drugs will face a steep 100 per cent duty, while heavy-duty trucks will carry a ...

Trump’s tariffs have given India’s economy a sharp shock, forcing it to confront its vulnerabilities and accelerate ...

In 2023, PM Modi called Donald Trump his special friend.  Two years on, 'that friendship' is being tested and it may be costing Indians jobs, visas and the ...

India rejected as "incorrect and baseless" remarks by NATO's chief that suggested Indian Prime Minister Narendra Modi was ...

US tariffs on Indian goods linked to Russian oil purchases; negotiations ongoing for resolution, potential increase in US oil ...

New Delhi has doubled down on domestic reforms and international engagement in the face of Washington’s tariffs, seeking ...

Indian pharma exporters are expected to face minimal impact from the US decision to impose a 100% tariff on patented ...

What It Means For India's Drug Makers US President Donald Trump has announced a 100% tariff on imported branded and patented ...

European countries are expected to face the most immediate and severe impact from the new U.S. tariffs on imported branded or ...